Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.41 |
| ▸ | SNCA | P37840 | 2/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 5/20 | 0.38 |
| ▸ | PPARA | Q07869 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30596301 | 0.98 | SNCA (0.60) | SNCAHIF1ASLC6A4SIGMAR1SLC6A2 | |
| Bromide SCHEMBL4171166 | 0.96 | SNCA (0.61) | SNCAHIF1ASLC6A4SIGMAR1SLC6A2 | |
| SCHEMBL8372338 | 0.92 | SNCA (0.55) | SNCAHIF1ASLC6A4SIGMAR1SLC6A2 | |
| SCHEMBL8603554 | 0.92 | SNCA (0.55) | SNCAHIF1ASLC6A4SIGMAR1SLC6A2 | |
| SCHEMBL8374368 | 0.92 | SNCA (0.55) | SNCAHIF1ASLC6A4SIGMAR1SLC6A2 | |
| SCHEMBL8375990 | 0.92 | SNCA (0.55) | SNCAHIF1ASLC6A4SIGMAR1SLC6A2 | |
| Hydrochloric Acid SCHEMBL2224568 | 0.92 | SNCA (0.48) | SNCAHIF1ASLC6A4SIGMAR1TSHR | |
| Hydrochloric Acid SCHEMBL2446696 | 0.89 | SNCA (0.69) | SNCAHIF1ASLC6A4SIGMAR1SLC6A2 | |
| Iodide SCHEMBL9321342 | 0.84 | SNCA (0.69) | SNCAHIF1ASLC6A4SIGMAR1SLC6A2 | |
| Bromide SCHEMBL39844 | 0.84 | SNCA (0.73) | SNCAHIF1ASLC6A4SIGMAR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116731701-A | Manganese-based zero-dimensional hybrid perovskite scintillator material, and preparation method and application thereof | 南京邮电大学 | 2023-09-12 | — | — | CN | claimed |
| JP-2005524748-A | — | — | 2005-08-18 | — | — | JP | claimed |
| US-6852417-B2 | Composition for improving adhesion of base-resistant fluoroelastomers to metal, ceramic or glass substrates | DUPONT DOW ELASTOMERS, LLC (US) | 2005-02-08 | — | — | US | claimed |
| EP-1501887-A1 | COMPOSITION FOR IMPROVING ADHESION OF BASE-RESISTANT FLUOROELASTOMERS TO METAL, CERAMIC OR GLASS SUBSTRATES | DUPONT DOW ELASTOMERS L.L.C. (US) | 2005-02-02 | — | — | EP | claimed |
| US-20030225189-A1 | Composition for improving adhesion of base-resistant fluoroelastomers to metal, ceramic or glass substrates | DUPONT DOW ELASTOMERS LLC | 2003-12-04 | — | — | US | claimed |
| WO-2003095535-A1 | COMPOSITION FOR IMPROVING ADHESION OF BASE-RESISTANT FLUOROELASTOMERS TO METAL, CERAMIC OR GLASS SUBSTRATES | DUPONT DOW ELASTOMERS L.L.C. (US) | 2003-11-20 | — | — | WO | claimed |
| WO-2026087965-A1 | COMPOSITION COMPRISING EPOXY RESIN WITH CONSTRAINED AROMATIC RINGS AND PHOTOBASE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260098005-A1 | NON-FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS | THE CHEMOURS COMPANY FC, LLC (US) | 2026-04-09 | — | — | US | disclosed |
| WO-2025200154-A1 | TWO-PART EPOXY COMPOSITION COMPRISING THIOL CURATIVE, AND CATALYST | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-10-02 | — | — | WO | disclosed |
| EP-4602105-A1 | CURABLE FLUOROELASTOMER COMPOSITIONS AND LOW-FRICTION CURED FLUOROELASTOMERS (FKM) FORMED THEREFROM | The Chemours Company FC, LLC (US) | 2025-08-20 | — | — | EP | disclosed |
| EP-4590761-A1 | NON-FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS | The Chemours Company FC, LLC (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4590762-A1 | FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS | The Chemours Company FC, LLC (US) | 2025-07-30 | — | — | EP | disclosed |
| CN-118943217-A | Photovoltaic module front plate and preparation method and application thereof | 苏州赛伍应用技术股份有限公司 | 2024-11-12 | — | — | CN | disclosed |
| EP-0049589-A1 | Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines | E.R. Squibb & Sons, Inc. (US) | 1982-04-14 | — | — | EP | disclosed |
| US-4316905-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1982-02-23 | — | — | US | disclosed |
| US-4311705-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1982-01-19 | — | — | US | disclosed |
| US-4243672-A | CARDIOVASCULAR DISORDERS; CARDIOTONIC AGENTS | PFIZER INC. (US) | 1981-01-06 | — | — | US | disclosed |
| EP-0009326-A2 | Pyrrolyl keto and amino acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them | Pfizer Limited (GB) | 1980-04-02 | — | — | EP | disclosed |
| US-4192868-A | ANTIINFLAMMATORY, ANALGESIC | CIBA-GEIGY CORPORATION (US) | 1980-03-11 | — | — | US | disclosed |
| US-4160842-A | Insecticidal [β-(substituted-phenyl)vinyl]cyclopropanecarboxylates | FMC CORPORATION (US) | 1979-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098005-A1 | NON-FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS | CBR1, NAF1, CBR3 | SLC6A2 4314/4885SLC6A3 4462/4885SNCA 4639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.